URETERIC CANCER METASTATIC

URETERIC CANCER METASTATIC was reported 25 times

These drug classes are most commonly taken by patients reporting URETERIC CANCER METASTATIC:

# Drug Count
0 Platinum-based Drug [EPC] 4
1 Angiotensin Converting Enzyme Inhibitor [EPC] 3
2 Kinase Inhibitor [EPC] 3
3 Calcium Channel Blocker [EPC] 2
4 Corticosteroid [EPC] 2
5 Dihydropyridine Calcium Channel Blocker [EPC] 2
6 Glycopeptide Antibacterial [EPC] 2
7 HMG-CoA Reductase Inhibitor [EPC] 2
8 Nonsteroidal Anti-inflammatory Drug [EPC] 2
9 Nucleoside Metabolic Inhibitor [EPC] 2
10 Opioid Agonist [EPC] 2
11 Provitamin D2 Compound [EPC] 2
12 Serotonin-3 Receptor Antagonist [EPC] 2
13 Aluminum Complex [EPC] 1
14 Aminosalicylate [EPC] 1
15 Angiotensin 2 Receptor Blocker [EPC] 1
16 Aromatase Inhibitor [EPC] 1
17 Azole Antifungal [EPC] 1
18 Benzodiazepine [EPC] 1
19 Bile Acid Sequestrant [EPC] 1
20 Cholinergic Muscarinic Antagonist [EPC] 1
21 Endothelin Receptor Antagonist [EPC] 1
22 Estrogen [EPC] 1
23 Expectorant [EPC] 1
24 Fluoroquinolone Antibacterial [EPC] 1
25 Influenza A M2 Protein Inhibitor [EPC] 1
26 Insulin Analog [EPC] 1
27 Integrin Receptor Antagonist [EPC] 1
28 Janus Kinase Inhibitor [EPC] 1
29 Loop Diuretic [EPC] 1
30 Lymphocyte Growth Factor [EPC] 1
31 Macrolide Antimicrobial [EPC] 1
32 Macrolide [EPC] 1
33 P2Y12 Platelet Inhibitor [EPC] 1
34 Parathyroid Hormone Analog [EPC] 1
35 Poly(ADP-Ribose) Polymerase Inhibitor [EPC] 1
36 Programmed Death Receptor-1 Blocking Antibody [EPC] 1
37 Prostacyclin Receptor Agonist [EPC] 1
38 Proteasome Inhibitor [EPC] 1
39 Serotonin Reuptake Inhibitor [EPC] 1
40 Tetracycline-class Drug [EPC] 1
41 Thiazide Diuretic [EPC] 1
42 Thiazide-like Diuretic [EPC] 1
43 Topoisomerase Inhibitor [EPC] 1
44 Vascular Endothelial Growth Factor Inhibitor [EPC] 1
45 Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC] 1
46 Vitamin B12 [EPC] 1
47 Vitamin C [EPC] 1
48 Vitamin D [EPC] 1
49 Xanthine Oxidase Inhibitor [EPC] 1
50 beta-Adrenergic Blocker [EPC] 1
51 mTOR Inhibitor Immunosuppressant [EPC] 1